Edition:
United Kingdom

People: Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

13.60USD
4:58pm BST
Change (% chg)

$0.11 (+0.82%)
Prev Close
$13.49
Open
$13.56
Day's High
$13.67
Day's Low
$13.37
Volume
72,706
Avg. Vol
226,651
52-wk High
$19.48
52-wk Low
$9.14

Maduck, Sean 

Mr. Sean Maduck is a Vice President of Sales and Marketing of Corcept Therapeutics Incorporated. He has served as our Senior Vice President, Commercial since April 2016. Prior to that, he served as our Vice President, Sales & Marketing. Mr. Maduck joined Corcept in 2012, bringing to the company 12 years of pharmaceutical, biotechnology and management experience. From 2002 to 2012, he held positions in the Finance, Portfolio Planning, and Commercial functions at Genentech. Prior to Genentech, he was an investment banking analyst at W.R Hambrecht + Company. He currently serves on the Board of Directors of the Cancer Support Community – San Francisco Bay Area. Mr. Maduck earned an A.B. from Dartmouth College, a B.E. in Biomedical Engineering from the Thayer School of Engineering at Dartmouth College, and a Masters in Management from the Stanford Graduate School of Business.

Basic Compensation

Total Annual Compensation, USD 634,667
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,171,400
Fiscal Year Total, USD 2,806,070

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 80,000 1,159,390.00
Name Fiscal Year Total

James Wilson

758,669

Joseph Belanoff

6,314,620

Gary Robb

2,845,670

Sean Maduck

2,806,070

Andreas Grauer

--

George Baker

267,889
As Of  31 Dec 2018